Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 13 (2005), Issue 3, Pages 155-160
http://dx.doi.org/10.1080/10647440500148321

The Efficacy and Safety of a Single Dose of Clindesse™ Vaginal Cream Versus a Seven-Dose Regimen of Cleocin® Vaginal Cream in Patients With Bacterial Vaginosis

1The Woman's Hospital of Texas, 7400 Fannin, Ste. 840, Houston 77054, Texas, USA
2The Woman's Clinic, Little Rock, Arkansas, USA

Copyright © 2005 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • R. Saul Levinson, Steven J. Mitan, Jana I. Steinmetz, David J. Gattermeir, Robert J. Schumacher, and James L. Joffrion, “An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations,” Clinical Therapeutics, vol. 27, no. 12, pp. 1894–1900, 2005. View at Publisher · View at Google Scholar
  • Linda O. Eckert, “Acute Vulvovaginitis,” New England Journal of Medicine, vol. 355, no. 12, pp. 1244–1252, 2006. View at Publisher · View at Google Scholar
  • Paul Nyirjesy, Matthew J. McIntosh, David J. Gattermeir, Robert J. Schumacher, Jana I. Steinmetz, and James L. Joffrion, “The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis,” American Journal of Obstetrics and Gynecology, vol. 194, no. 5, pp. 1277–1282, 2006. View at Publisher · View at Google Scholar
  • Paul Nyirjesy, Matthew J. McIntosh, Jana I. Steinmetz, Robert J. Schumacher, and James L. Joffrion, “The Effects of Intravaginal Clindamycin and Metronidazole Therapy on Vaginal Mobiluncus Morphotypes in Patients With Bacterial Vaginosis,” Sexually Transmitted Diseases, vol. 34, no. 4, pp. 197–202, 2007. View at Publisher · View at Google Scholar
  • David Guay, “Update on clindamycin in the management of bacterial, fungal and protozoal infections,” Expert Opinion on Pharmacotherapy, vol. 8, no. 14, pp. 2401–2444, 2007. View at Publisher · View at Google Scholar
  • Judy Y. Chen, Haijun Tian, and Richard H. Beigi, “Treatment Considerations for Bacterial Vaginosis and the Risk of Recurrence,” Journal of Women's Health, vol. 18, no. 12, pp. 1997–2004, 2009. View at Publisher · View at Google Scholar
  • Sonal Gupta, Reema Gabrani, Javed Ali, and Shweta Dang, “Exploring novel approaches to vaginal drug delivery,” Recent Patents on Drug Delivery and Formulation, vol. 5, no. 2, pp. 82–94, 2011. View at Publisher · View at Google Scholar
  • Sharon L. Hillier, Paul Nyirjesy, Arthur S. Waldbaum, Jane R. Schwebke, Franklin G. Morgan, Nikki A. Adetoro, and Carol J. Braun, “Secnidazole Treatment of Bacterial Vaginosis,” Obstetrics & Gynecology, vol. 130, no. 2, pp. 379–386, 2017. View at Publisher · View at Google Scholar
  • Melinda A.B. Petrina, Lisa A. Cosentino, Lorna K. Rabe, and Sharon L. Hillier, “Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin,” Anaerobe, 2017. View at Publisher · View at Google Scholar